Arden Trust CO Gilead Sciences, Inc. Transaction History

Arden Trust CO

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 03, 2024	SELL	$71.58 - $87.29 $32,640 - $39,804	-456 Reduced 9.83%	4,182 $306,000
Q4 2023 Jan 04, 2024	BUY	$73.27 - $83.09 $34,070 - $38,636	465 Added 11.14%	4,638 $375,000
Q3 2023 Oct 10, 2023	BUY	$73.94 - $80.67 $66,546 - $72,603	900 Added 27.5%	4,173 $312,000
Q2 2023 Jul 14, 2023	SELL	$76.01 - $86.7 $73,121 - $83,405	-962 Reduced 22.72%	3,273 $253,000
Q1 2023 Apr 14, 2023	SELL	$77.31 - $88.08 $159,413 - $181,620	-2,062 Reduced 32.75%	4,235 $351,000
Q4 2022 Jan 20, 2023	SELL	$62.32 - $89.47 $27,794 - $39,903	-446 Reduced 6.61%	6,297 $0
Q2 2022 Jul 12, 2022	BUY	$57.72 - $65.01 $26,666 - $30,034	462 Added 7.36%	6,743 $417,000
Q1 2022 Apr 11, 2022	SELL	$57.92 - $72.58 $29,481 - $36,943	-509 Reduced 7.5%	6,281 $373,000
Q4 2021 Jan 24, 2022	BUY	$64.88 - $73.64 $65,528 - $74,376	1,010 Added 17.47%	6,790 $493,000
Q3 2021 Oct 12, 2021	SELL	$67.69 - $73.03 $16,110 - $17,381	-238 Reduced 3.95%	5,780 $404,000
Q2 2021 Jul 19, 2021	SELL	$63.47 - $69.35 $2,856 - $3,120	-45 Reduced 0.74%	6,018 $414,000
Q1 2021 Apr 23, 2021	BUY	$60.0 - $68.46 $363,780 - $415,072	6,063 New	6,063 $392,000
Q2 2020 Jul 09, 2020	SELL	$72.34 - $84.0 $224,977 - $261,240	-3,110 Closed	0 $0
Q1 2020 Apr 16, 2020	SELL	$62.63 - $80.22 $13,653 - $17,487	-218 Reduced 6.55%	3,110 $233,000
Q4 2019 Jan 17, 2020	SELL	$61.62 - $67.78 $61 - $67	-1 Reduced 0.03%	3,328 $216,000
Q3 2019 Oct 09, 2019	BUY	$62.51 - $69.0 $208,095 - $229,701	3,329 New	3,329 $211,000

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

Stay updated on Arden Trust CO with notifications on news.